Is Fair to Shareholders Halper Sadeh encourages Axonics shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Axonics and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Axonics shareholders; (2) determine whether Boston Scientific is underpaying for Axonics; and (3) disclose all material information necessary for Axonics shareholders to adequately assess and value the merger consideration. On behalf of Axonics shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.